Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Palliative Medicine ; 36(1 SUPPL):53, 2022.
Article in English | EMBASE | ID: covidwho-1916749

ABSTRACT

Background/aims: Short-term specialized palliative homecare that is initiated timely based on complex needs has been advocated for older people with frailty. But there is insufficient evidence on the feasibility of such an intervention. To assess the feasibility and preliminary effectiveness of a timely shortterm specialized palliative homecare intervention (i.e., Frailty+) for older people with frailty and family. Methods: Pilot randomised controlled trial and process evaluation. Eligible patients were 70 years or older, had a clinical frailty score 5-7, complex needs and about to be discharged home from hospital. They were randomly assigned (1:1) to Frailty+ or standard care. The Frailty+ group received specialized palliative care by a palliative homecare nurse over 8 weeks, who followed guides for home visits. The primary endpoint was change on a sum score based on five key symptoms, i.e., breathlessness, pain, anxiety, constipation, drowsiness, over 8 weeks. Feasibility, implementation, mechanisms and context were assessed post-intervention using mixed methods. We used thematic and descriptive statistical analyses. Results: 37 patients were randomly assigned to Frailty+ group (n=19, mean age 84y) or standard care (n=18, mean age 84y) and 26 family carers. The Frailty+ group received at least one home visit, as intended. Hospital care staff reported difficulties in patient identification. Patients and family reported positive views on the home visits, nurses that the guides were often not useful. Most important contextual factors were related to the COVID-19 crisis e.g., less continuity of care. Mean sum scores on primary outcome at baseline was 6.0 in Frailty+ and 5.6 in the control group, at 8-weeks was 4.5 in Frailty+ and 4.1 in the control group (adjusted ratio 1.0). Conclusions: Frailty+ was well received by patients and family and to a lesser extent healthcare providers. Based on these results, further refinement of Frailty+ and RCT design is needed to optimize the intervention and evaluation.

SELECTION OF CITATIONS
SEARCH DETAIL